Wei-Ping Ma

522 total citations
26 papers, 443 citations indexed

About

Wei-Ping Ma is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Wei-Ping Ma has authored 26 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Oncology. Recurrent topics in Wei-Ping Ma's work include Protein Tyrosine Phosphatases (6 papers), Galectins and Cancer Biology (6 papers) and Drug Transport and Resistance Mechanisms (3 papers). Wei-Ping Ma is often cited by papers focused on Protein Tyrosine Phosphatases (6 papers), Galectins and Cancer Biology (6 papers) and Drug Transport and Resistance Mechanisms (3 papers). Wei-Ping Ma collaborates with scholars based in China, United States and Australia. Wei-Ping Ma's co-authors include Qing Han, Jia Li, Jing-Ya Li, Lixin Gao, Fajun Nan, Huiqing Jiang, Yanli Yan, Xiaoping Liu, Yu Guo and Xiao‐Li Xie and has published in prestigious journals such as Gastroenterology, Biochemical and Biophysical Research Communications and Carbohydrate Polymers.

In The Last Decade

Wei-Ping Ma

25 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei-Ping Ma China 12 237 52 48 48 45 26 443
Wataru Komatsu Japan 13 338 1.4× 62 1.2× 49 1.0× 43 0.9× 29 0.6× 27 688
Lina Zhao China 16 388 1.6× 59 1.1× 52 1.1× 109 2.3× 19 0.4× 39 713
Yanfei Wei China 14 291 1.2× 61 1.2× 64 1.3× 68 1.4× 52 1.2× 33 724
Xia Yang China 13 375 1.6× 37 0.7× 44 0.9× 181 3.8× 26 0.6× 20 786
Po‐Han Lin Taiwan 13 156 0.7× 57 1.1× 33 0.7× 48 1.0× 15 0.3× 20 444
Zuquan Zou China 13 216 0.9× 27 0.5× 64 1.3× 66 1.4× 24 0.5× 20 440
Karvannan Kanchana China 9 314 1.3× 36 0.7× 27 0.6× 43 0.9× 65 1.4× 22 548
Jun Pei China 12 278 1.2× 50 1.0× 143 3.0× 94 2.0× 23 0.5× 50 764
Senping Cheng China 12 365 1.5× 48 0.9× 60 1.3× 104 2.2× 32 0.7× 16 768
Pengqi Wang China 15 276 1.2× 20 0.4× 49 1.0× 43 0.9× 15 0.3× 26 909

Countries citing papers authored by Wei-Ping Ma

Since Specialization
Citations

This map shows the geographic impact of Wei-Ping Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Ping Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Ping Ma more than expected).

Fields of papers citing papers by Wei-Ping Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Ping Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Ping Ma. The network helps show where Wei-Ping Ma may publish in the future.

Co-authorship network of co-authors of Wei-Ping Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Ping Ma. A scholar is included among the top collaborators of Wei-Ping Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Ping Ma. Wei-Ping Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Chaoming, Jinman Zhang, Xianfeng Wei, et al.. (2023). Design, Synthesis, and Biological Evaluation of Marine Lissodendrins B Analogues as Modulators of ABCB1-Mediated Multidrug Resistance. Marine Drugs. 21(5). 314–314. 4 indexed citations
3.
Hai, Yang, Wei-Ping Ma, Mei‐Yan Wei, et al.. (2022). Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma. European Journal of Medicinal Chemistry. 232. 114166–114166. 3 indexed citations
4.
5.
Ma, Wei-Ping, et al.. (2022). Antiperspirant effects and mechanism investigation of Mulisan decoction in rats based on plasma metabolomics. Pharmaceutical Biology. 60(1). 1055–1062. 2 indexed citations
6.
Ma, Wei-Ping, Haihua Li, Ming Liu, & Hongbing Liu. (2021). Effects of simulated digestion in vitro on the structure and macrophages activation of fucoidan from Sargassum fusiforme. Carbohydrate Polymers. 272. 118484–118484. 18 indexed citations
7.
Ma, Wei-Ping, Haihua Li, Xiaoqing Ma, et al.. (2020). Haimufang decoction, a Chinese medicine formula for lung cancer, arrests cell cycle, stimulates apoptosis in NCI-H1975 cells, and induces M1 polarization in RAW 264.7 macrophage cells. BMC Complementary Medicine and Therapies. 20(1). 243–243. 10 indexed citations
8.
9.
10.
Ma, Wei-Ping, Xin Wang, Huan Dong, et al.. (2018). Internal biliary drainage superior to external biliary drainage in improving gut mucosa barrier because of goblet cells and mucin-2 up-regulation. Bioscience Reports. 38(3). 74 indexed citations
11.
Liu, Xiaoping, et al.. (2017). Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling. Biochemical and Biophysical Research Communications. 490(3). 1112–1118. 20 indexed citations
12.
Wang, Na, Qing Han, Gai Wang, et al.. (2016). Resveratrol Protects Oxidative Stress-Induced Intestinal Epithelial Barrier Dysfunction by Upregulating Heme Oxygenase-1 Expression. Digestive Diseases and Sciences. 61(9). 2522–2534. 81 indexed citations
13.
Yin, Jianpeng, Chunlan Tang, Lixin Gao, et al.. (2014). Design and synthesis of paracaseolide A analogues as selective protein tyrosine phosphatase 1B inhibitors. Organic & Biomolecular Chemistry. 12(21). 3441–3441. 20 indexed citations
14.
Chen, Yueting, Chunlan Tang, Wei-Ping Ma, et al.. (2013). Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy. European Journal of Medicinal Chemistry. 69. 399–412. 19 indexed citations
15.
Li, Yuanyuan, Li-Fang Yu, Lína Zhang, et al.. (2013). Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice. Toxicology and Applied Pharmacology. 273(2). 325–334. 52 indexed citations
16.
He, Haibing, Lixin Gao, Wei-Ping Ma, et al.. (2012). Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B. Bioorganic & Medicinal Chemistry Letters. 22(23). 7237–7242. 16 indexed citations
17.
Sun, Liang‐Peng, Wei-Ping Ma, Lixin Gao, et al.. (2012). Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 28(6). 1199–1204. 12 indexed citations
18.
Sun, Liang‐Peng, Qiang Shen, Wei-Ping Ma, et al.. (2011). Synthesis and biological evaluation of (±)-3-(2-(2-fluorobenzyloxy) naphthalen-6-yl)-2-aminopropanoic acid derivatives as novel PTP1B inhibitors. European Journal of Medicinal Chemistry. 46(9). 3630–3638. 10 indexed citations
19.
Luan, Feng, et al.. (2007). Classification of estrogen receptor-β ligands on the basis of their binding affinities using support vector machine and linear discriminant analysis. European Journal of Medicinal Chemistry. 43(1). 43–52. 11 indexed citations
20.
Ma, Wei-Ping, Paul W. Brown, & Sridhar Komarneni. (1996). Sequestration of Cesium and Strontium by Tobermorite Synthesized from Fly Ashes. Journal of the American Ceramic Society. 79(6). 1707–1710. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wataru Komatsu Breakdown of academic impact, for papers by Lina Zhao Breakdown of academic impact, for papers by Yanfei Wei Breakdown of academic impact, for papers by Xia Yang Breakdown of academic impact, for papers by Po‐Han Lin Breakdown of academic impact, for papers by Zuquan Zou Breakdown of academic impact, for papers by Karvannan Kanchana Breakdown of academic impact, for papers by Jun Pei Breakdown of academic impact, for papers by Senping Cheng Breakdown of academic impact, for papers by Pengqi Wang
Rankless by CCL
2026